|
Saturday, 12 April 2008 |
|
Sonoenteroclysis, a new sonographic way in evaluating and diagnosing little bowel disorders is an effective alternative to the common way of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. |
|
Read more...
|
|
|
Friday, 11 April 2008 |
|
Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited (BSE: Glenmark). |
|
Read more...
|
|
|
Tuesday, 08 April 2008 |
|
Administration of omega-3 fatty acid supplements did not appear to advance the rate of relapse in patients with Crohn's disease, according to a study released on April 9, 2008 in JAMA. |
|
Read more...
|
|
|
Tuesday, 08 April 2008 |
|
The GI Company, Inc. |
|
Read more...
|
|
|
Tuesday, 08 April 2008 |
|
The GI Company, Inc. |
|
Read more...
|
|
|
Monday, 07 April 2008 |
|
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced that its partner, GlaxoSmithKline (GSK), has received approval from the U.S. Food and Drug Administration (FDA) for ROTARIX® for the prevention of rotavirus gastroenteritis in infants. |
|
Read more...
|
|
|
Sunday, 06 April 2008 |
|
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has accepted Rotarix® [Rotavirus Vaccine, live, oral] for the prevention of rotavirus gastroenteritis in infants. |
|
Read more...
|
|
|
Friday, 04 April 2008 |
|
The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. |
|
Read more...
|
|
|
Friday, 04 April 2008 |
|
The Fundamentals of Laparoscopic Surgery (FLS), a joint educational program from the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the American College of Surgeons (ACS), has received a $1. |
|
Read more...
|
|
|
Thursday, 03 April 2008 |
|
A new Mayo Clinic study finds that patients who are 50 or older and take multiple immunosuppressive medications for inflammatory bowel disease have a higher risk for developing infections. The study is published in this month's issue of Gastroenterology. |
|
Read more...
|
|
|
Wednesday, 02 April 2008 |
|
1st April 2008: A new safefood study - The Economic Impact of Gastroenteritis on the Island of Ireland has revealed the total burden of gastroenteritis on the economy for the island of Ireland is estimated at over €135 million per annum. |
|
Read more...
|
|
|
Wednesday, 02 April 2008 |
|
Natural sugars found in breast milk that are now included in prebiotic foods may help in the fight against Salmonella and other food poisoning bacteria, scientists heard today (Wednesday 2 April 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh... |
|
Read more...
|
|
|
Wednesday, 02 April 2008 |
|
Obesity is more than a cosmetic concern since it increases a person's risk for developing high blood pressure, diabetes and many other serious health problems. It's well understood that consuming more calories than you expend through exercise and daily activities causes weight gain. |
|
Read more...
|
|
|
Tuesday, 01 April 2008 |
|
Epistem (LSE: EHP) announced that Exponential Biotherapies, Inc. (EBI) of Virginia, USA, have contracted Epistem to provide their specialised preclinical efficacy testing services for agents likely to defend the gastrointestinal tract against radiation damage. |
|
Read more...
|
|
|
Monday, 31 March 2008 |
|
Ethicon Endo-Surgery announced that the company has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the SEDASYS™ System, the first computer-assisted personalized sedation (CAPS) system. |
|
Read more...
|
|
|
Friday, 28 March 2008 |
|
New clinical data from a phase II study affirms the competitive profile of Orexo's product OX17 in GERD patients, i.e. quick, effective and sustained inhibition of gastric acid production, a prerequisite for effective symptom relief in the patient. |
|
Read more...
|
|
|
Thursday, 27 March 2008 |
|
The GI Company, Inc., a privately held developer of gastrointestinal therapeutics, announced that an abstract detailing results from a Phase II clinical trial (2006 - ITF - 009) has been accepted for oral presentation at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO). |
|
Read more...
|
|
|
Thursday, 27 March 2008 |
|
Repligen Corporation (Nasdaq: RGEN) announced that the Company has initiated a Phase 3 clinical trial to evaluate the use of RG1068, synthetic human secretin, to enhance the assessment of pancreatic duct structures by magnetic resonance imaging (MRI). |
|
Read more...
|
|
|
Wednesday, 26 March 2008 |
|
Researchers at UT Southwestern Medical Center have been awarded a $6.5 million grant from the National Institute of Allergy and Infectious Diseases to develop a new anti-microbial compound to goal bacterial pathogens like Salmonella and Escherichia coli. |
|
Read more...
|
|
|
Wednesday, 26 March 2008 |
|
Due to the rise in the incidence of esophageal cancers in the United States, and as a result of weighty scientific advances in the area of Barrett's esophagus, physician experts from the American College of Gastroenterology have released updated guidelines for the diagnosis, surveillance and... |
|
Read more...
|
|
|
Tuesday, 25 March 2008 |
|
Nearly half of all HIV-positive African adults who become infected with Salmonella die from what otherwise would be a seven-day bout of diarrhea. Now, UC Davis School of Medicine scientists have discovered how salmonella becomes lethal for AIDS patients. |
|
Read more...
|
|
|
Thursday, 20 March 2008 |
|
The Incidence of Salmonella enteritidis infection is usual in hospitals for children and the old, and amongst immuno-suppressed individuals. Salmonella enteritidis can be transmitted to humans through the food production chain. |
|
Read more...
|
|
|
Thursday, 20 March 2008 |
|
A soft pancreatic texture with a narrow pancreatic ductal size creates a high risk for the development of a pancreatic fistula after pancreaticoduodenectomy, frequently leading to death. |
|
Read more...
|
|
|
Thursday, 20 March 2008 |
|
In rats with experimental colitis, the marked increase in bacterial translocation in postcolitis rats has been reversed by melatonin administration. This is because of melatonin's anti-inflammatory and anti-apoptotic effects. |
|
Read more...
|
|
|
Thursday, 20 March 2008 |
|
Since December 2007, cholera outbreaks have affected thousands of people in the cities of Lubumbashi and Likasi in southern Katanga province, Democratic Republic of Congo. For the last 3 weeks, on the contrary, the number of new patients at MSF clinics in these areas have been decreasing. |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
Probiotic bacteria, defined as living microorganisms that have beneficial effects on human health, have been used for the prevention and treatment of a diverse range of disorders. However, the ways in which probiotic bacteria elicit their health effects are not completely understood. |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
The Gram negative bacterium H pylori is involved in the pathogenesis of several gastrointestinal diseases, ultimately leading to gastric carcinoma. Adhesion of the bacteria to the gastric mucosa is an valuable step for colonization and infection. |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
Historically anaemia, which is associated with colorectal cancer, has been attributed to blood loss. Previous studies have elegantly shown that the anti-microbial peptide hepcidin can also induce anaemia as a consequence of infection and or inflammation. |
|
Read more...
|
|
|
Wednesday, 19 March 2008 |
|
Management of ingested foreign bodies is a usual clinical meet. Complications of this pathology are dependent on a patient's age, the nature and localization of the foreign body, the presence of a perforation, and first management procedures. |
|
Read more...
|
|
|
Tuesday, 18 March 2008 |
|
Amgen Limited UK and Lab21 have announced their partnership to introduce a new genetic therapy test for enhanced bowel cancer treatment in the UK. |
|
Read more...
|
|